Thermo Fisher to Acquire Brammer Bio, an Industrial Info Market Brief
Thermo Fisher to Acquire Brammer Bio, an Industrial Info Market Brief
Off the heels of purchasing Patheon in 2017, Thermo Fisher is acquiring Brammer Bio, a viral vector contract development and manufacturing organization (CDMO) for gene therapy innovators, for $1.7 billion.
Subscribe Now!(All Fields Required)
Related Articles
Articles related to this company
- GSK Sells Irish Plant to Thermo Fisher in $102 Million Deal
- Thermo Fisher Scientific Sees Record Third Quarter, Thanks to Growth in Chi...
- France Plans $55 Billion in Windfarms as Offshore Projects Gain Momentum
- Africa's Fertilizer Demand Sparks $5.8 Billion of Projects
- Poland's PGE Plans $7 Billion Renewable Energy Push
Quick Links
- Home
- About Us
- Contact Us
- For Traders
Global Market Intelligence
- GMI Database Platform
- GMI Platform Tools
- Industry Coverage
- Analytics & Insights
- Advertising
